Literature DB >> 15325949

Medication errors associated with anticoagulant therapy in the hospital.

John Fanikos1, Carl Stapinski, Sophia Koo, Nils Kucher, Kanella Tsilimingras, Samuel Z Goldhaber.   

Abstract

Anticoagulation in hospitalized patients is frequently associated with medication errors. To determine the extent and severity of this problem, we reviewed consecutively reported, anticoagulation-related medication errors over a 3-year period. We identified 130 medication errors. There were 1.67 medication errors for every 1,000 patients treated with anticoagulants. These were most often associated with unfractionated heparin (66.2%), followed by warfarin (21.5%), low-molecular-weight heparin (9.2%), argatroban (1.5%), and lepirudin (1.5%). There were no deaths attributed to any anticoagulant medication errors, but 6.2% of patients required medical intervention and 1.5% needed prolonged hospitalization. Medication errors frequently occur with anticoagulant therapy in hospitalized patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325949     DOI: 10.1016/j.amjcard.2004.04.075

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Establishing an inpatient anticoagulation service: a step by step review.

Authors:  John Viercinski; Lynda Thomson; Joseph Wilson; Geno J Merli
Journal:  J Thromb Thrombolysis       Date:  2007-09-29       Impact factor: 2.300

2.  Neonatal heparin overdose-a multidisciplinary team approach to medication error prevention.

Authors:  Jason Arimura; Robert L Poole; Michael Jeng; William Rhine; Paul Sharek
Journal:  J Pediatr Pharmacol Ther       Date:  2008-04

Review 3.  Regulatory, legislative, and policy updates with anticoagulant use.

Authors:  John Fanikos; Leo F Buckley; Ahmed Aldemerdash; Kimberly J Terry; Gregory Piazza; Jean M Connors; Samuel Z Goldhaber
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

4.  Anticoagulation-associated adverse drug events.

Authors:  Gregory Piazza; Thanh Nha Nguyen; Deborah Cios; Matthew Labreche; Benjamin Hohlfelder; John Fanikos; Karen Fiumara; Samuel Z Goldhaber
Journal:  Am J Med       Date:  2011-12       Impact factor: 4.965

5.  Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum.

Authors:  Edith A Nutescu; Ann K Wittkowsky; Allison Burnett; Geno J Merli; Jack E Ansell; David A Garcia
Journal:  Ann Pharmacother       Date:  2013-04-12       Impact factor: 3.154

6.  Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.

Authors:  Patrick P Kneeland; Margaret C Fang
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

7.  Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis.

Authors:  Amanda R Patrick; Wolfgang C Winkelmayer; Jerry Avorn; Michael A Fischer
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 8.  Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.

Authors:  Marcie J Hursting; Joseph Soffer
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Medication errors involving anticoagulants: Data from the Danish patient safety database.

Authors:  Jakob Nørgaard Henriksen; Lars Peter Nielsen; Annemarie Hellebek; Birgitte Klindt Poulsen
Journal:  Pharmacol Res Perspect       Date:  2017-04-03

10.  The Effect of Digitization on the Safe Management of Anticoagulants.

Authors:  Jodie A Austin; Michael A Barras; Leanna S Woods; Clair M Sullivan
Journal:  Appl Clin Inform       Date:  2022-07-27       Impact factor: 2.762

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.